1 | 1 mg QD to 15 mg QD PF-06649751 | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
2 | 15 mg QD PF-06649751 | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
3 | 3 mg QD to 15 mg QD PF-06649751 | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
4 | 7 mg QD to 15 mg QD PF-06649751 | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |